Volume CT

NeuroLogica Announces a Research Collaboration with Massachusetts General Hospital to Pilot Photon Counting Computed Tomography at the Patient’s Point-Of-Care Using OmniTom Elite CT

Retrieved on: 
Tuesday, July 13, 2021
Research, Medical devices, Hospitals, Other Health, Biotechnology, Managed care, Radiology, General Health, Health, Science, Optics, Tomography, Photonics, Medicine, CT scan, Multidimensional signal processing, Radiology, Photon counting, Volume CT, Applied sciences

NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.

Key Points: 
  • NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.
  • View the full release here: https://www.businesswire.com/news/home/20210713005323/en/
    NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care.
  • Pending FDA 510(k) clearance of this technology, Massachusetts General Hospital will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.
  • "We are excited about our collaboration with NeuroLogica, said Raj Gupta, MD, PhD, Director, Ultra-High-Resolution Volume CT Lab, Massachusetts General Hospital.